Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Bausch Health Announces 2023 Annual Meeting of Shareholder Results

LAVAL, QC / ACCESSWIRE / May 17, 2023 / Bausch Health Companies Inc. (NYSE: BHC)(TSX:BHC) today announced the results of its 2023 annual meeting of shareholders (the "Annual Meeting").

The 10 directors nominated at the Company's Annual Meeting held on May 16, 2023, were elected by a vote of the Company's shareholders. The detailed results of the vote for the election of directors are set out below:

Name

For

Withheld

Broker Non-Votes

Thomas J. Appio

190,930,071

2,850,553

69,221,265

Brett M. Icahn

169,686,359

24,094,265

69,221,265

Sarah B. Kavanagh

189,301,790

4,478,834

69,221,265

Steven D. Miller

181,093,705

12,686,919

69,221,265

Dr. Richard C. Mulligan

174,330,012

19,450,612

69,221,265

John A. Paulson

182,711,655

11,068,969

69,221,265

Robert N. Power

183,421,864

10,358,760

69,221,265

Russel C. Robertson

189,249,474

4,531,150

69,221,265

Thomas W. Ross, Sr.

190,210,369

3,570,255

69,221,265

Amy B. Wechsler, M.D.

190,174,239

3,606,385

69,221,265

Shareholders also approved the non-binding advisory vote on the compensation of the Company's named executive officers and an annual frequency of future advisory votes on the compensation of the Company's named executive officers approved an amendment to the Company's 2014 Omnibus Incentive Plan (the "Plan") to increase the number of common shares authorized for issuance thereunder, and appointed PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm until the close of the Company's 2024 annual meeting of shareholders.

For the purposes of Toronto Stock Exchange (TSX) approval with respect to the Plan, the Company relied on the exemption set forth in Section 602.1 of the TSX Company Manual, which provides that the TSX will not apply its standards to certain transactions involving eligible inter-listed issuers on a recognized exchange, such as the NYSE.

The final vote tabulation on all matters voted on at the meeting will be reported to the U.S. Securities and Exchange Commission on a current report on Form 8-K, and such report will be made available on the Company's SEDAR profile and on the Company's website at www.bauschhealth.com.

About Bausch Health

Bausch Health Companies Inc. (NYSE/TSX:BHC) is a global diversified pharmaceutical company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals and eye health, through our controlling ownership of Bausch + Lomb Corporation. With our leading durable brands, we are delivering on our commitments as we build an innovative company dedicated to advancing global health. For more information, visit www.bauschhealth.com and connect with us on Twitter and LinkedIn.

Forward-looking Statements

This news release may contain forward-looking statements about Bausch Health and Bausch + Lomb, which may generally be identified by the use of the words "anticipates," "hopes," "expects," "intends," "plans," "should," "could," "would," "may," "believes," "subject to" and variations or similar expressions, including statements about the timing and details of the future plans for Bausch + Lomb and its future performance. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. In addition, actual results are subject to other risks and uncertainties that relate more broadly to Bausch Health's and Bausch + Lomb's overall business, including those more fully described in Bausch + Lomb's and Bausch Health's respective filings with the U.S. Securities and Exchange Commission and the Canadian Securities Administrators, which factors are incorporated herein by reference. Readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. Bausch Health and Bausch + Lomb undertake no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this news release or to reflect actual outcomes, unless required by law.

Investor Contact:

Media Contact:

Mark Maico

Kevin Wiggins

ir@bauschhealth.com

corporate.communications@bauschhealth.com

(908) 541-2102

(908) 541-3785

(877) 281-6642 (toll free)

SOURCE: Bausch Health Companies Inc



View source version on accesswire.com:
https://www.accesswire.com/755427/Bausch-Health-Announces-2023-Annual-Meeting-of-Shareholder-Results

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  218.76
-3.27 (-1.47%)
AAPL  260.12
-2.65 (-1.01%)
AMD  239.53
+1.50 (0.63%)
BAC  51.20
-0.33 (-0.63%)
GOOG  255.19
+3.85 (1.53%)
META  738.92
+5.65 (0.77%)
MSFT  523.62
+5.96 (1.15%)
NVDA  182.51
+1.35 (0.75%)
ORCL  275.52
+0.37 (0.13%)
TSLA  440.89
-1.71 (-0.39%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.